Trezix

Product NDC: 66992-840
Requested package NDC: 66992-840-10
11-digit product format: 669920840
Labeler code: 66992
Product ID: 66992-840_34095d36-7525-4953-bce7-d86031545d5a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: acetaminophen, caffeine, dihydrocodeine bitartrate
Dosage form: CAPSULE
Route: ORAL
Labeler: Wraser Llc
Application: ANDA204785
Marketing category: ANDA
Marketing start: 2014-12-01
Marketing end: 0000-00-00
Substance: ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Active strength: 321 mg/1; mg/1; mg/1
Pharmacologic classes: Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule: CIII
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	66992-840	66992-840-10	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A204785-001	TREZIX	ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE	320.5MG;30MG;16MG	CAPSULE / ORAL			2014-11-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A204785-001	TREZIX	320.5MG;30MG;16MG	CAPSULE / ORAL	2014-11-26	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
75d4bef7-334c-4a95-abb5-bff9def24114	Product name	2	20260112
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
11939cf5-0ea7-5df5-5127-00a7ce07fd7f	Product name	5	20250115
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
88300afc-e1c4-ad17-c80b-4957f1b809a5	Product name	5	20250113
4eddd6ca-259a-4c6c-a3a4-2025015ce043	Product name	7	20240611
16cde546-8deb-4df2-a072-dab5566ede95	Product name	1	20231003
20ab58de-c64a-4ec2-9210-3aa3fae2b66f	Product name	1	20230808
a3631b20-02d1-41d7-8187-5e5e850b9e80	Product name	1	20230306
79e1734e-f721-4d46-978a-be382f771672	Product name	2	20230110
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
06cc817f-60e0-4473-8e6b-c44d11dc5af6	Product name	9	20220921
92ead9ae-674d-4eee-a492-c385d496891f	Product name	3	20220308
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
103b151b-b17f-42ac-8624-3ef62f5e2975	Product name	2	20200507
b8497372-efe9-9dde-fa2d-59be9761aa64	Product name	9	20200428
20c8cafe-5cfc-44f8-a9be-a664f437f780	Product name	2	20200225
3a16d77a-e865-468a-aedf-6e58913c1c21	Product name	3	20190619
2a0c98e1-033f-4e0d-a0da-b5291ffbe880	Product name	1	20190320
00d531e4-b130-8c52-eaf9-826cbb6f15dd	Product name	3	20190205
aa0f353d-f35e-62e4-4e1f-5b563f01c659	Product name	9	20190205
22d922aa-c443-d9f3-b23c-03b03a9ad31c	Product name	7	20181220
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
377068df-225f-7318-a910-a1987cdfa361	Product name	3	20170608
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
23475c0b-a5b5-4fec-b97f-acca901eae6a	Product name	1	20140718
105ef617-6fa4-6713-326f-72ec8a6b75a9	Product name	1	20140508
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
3ed6b849-48b8-8899-c288-6eeb396123b6	Product name	1	20140508
47fd879b-91c5-e1e5-130f-29d082a871ec	Product name	1	20140508
53855190-7124-8179-f018-e792f7c27f28	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
84fb0b3d-1d72-b672-bc70-2b676a23e7e0	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
96c5169b-5b9d-547d-bf22-d688d91866e4	Product name	1	20140508
b8e0daf1-fb81-290b-c0bf-873be19ef775	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
c35d1ac8-8885-2ee1-6c52-5a715b242c00	Product name	1	20140508
c8753a88-edde-8e17-a396-705537b52cee	Product name	1	20140508
cd4f9ae2-1343-ecd2-ce0f-97db0c2b51ce	Product name	1	20140508
cf3a804d-0326-aa22-0142-c184b5657d85	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
d83c592c-dd97-4cbf-36ac-13da806684bd	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
66992-840-10	2024-01-30	C162847	48780-1	ba0f9c33-0ffd-a910-e053-dadaa90a0b85	TREZIX™ Capsules
66992-840-10	2021-02-02	C162847	48780-1	ba0f9c33-0ffd-a910-e053-dadaa90a0b85	TREZIX™ Capsules
66992-840-10	2021-01-29	C162847	48780-1	ba0f9c33-0ffd-a910-e053-dadaa90a0b85	TREZIX™ Capsules

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
66992-840-10	Trezix	100 in 1 BOTTLE	CAPSULE	100		12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
66992-840-10	EA - Each	66992-840	0b6251be-5b91-48cf-8a9d-f682c949927b	1	2015-01-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
CAFFEINE	ACTIVE INGREDIENT	3G6A5W338E	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
DIHYDROCODEINE BITARTRATE	ACTIVE INGREDIENT	8LXS95BSA9	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
CAFFEINE	ACTIVE MOIETY	3G6A5W338E	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
DIHYDROCODEINE	ACTIVE MOIETY	N9I9HDB855	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66992-840	TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC]	12	Legacy NDC, 1 package rows	20210204_a519a201-bcfd-4029-9bdf-fc3e03f975ac.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Trezix	ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE	Proficient Rx LP	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	2022-05-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204785 application number: ANDA204785

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE
8LXS95BSA9	DIHYDROCODEINE BITARTRATE	5965-13-9	DIHYDROCODEINE BITARTRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1596108	acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule	PSN	a519a201-bcfd-4029-9bdf-fc3e03f975ac	12
1190201	TREZIX 16 MG / 320.5 MG / 30 MG Oral Capsule	PSN	a519a201-bcfd-4029-9bdf-fc3e03f975ac	12
1190201	acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]	SBD	a519a201-bcfd-4029-9bdf-fc3e03f975ac	12
1596108	acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule	SCD	a519a201-bcfd-4029-9bdf-fc3e03f975ac	12
1596108	APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule	SY	a519a201-bcfd-4029-9bdf-fc3e03f975ac	12
1190201	APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]	SY	a519a201-bcfd-4029-9bdf-fc3e03f975ac	12
1190201	Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule	SY	a519a201-bcfd-4029-9bdf-fc3e03f975ac	12
1596108	acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule	PSN	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	6
1190201	TREZIX 16 MG / 320.5 MG / 30 MG Oral Capsule	PSN	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	6
1190201	acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]	SBD	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	6
1596108	acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule	SCD	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	6
1596108	APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule	SY	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	6
1190201	APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]	SY	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	6
1190201	Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule	SY	45c3c2a1-6a89-471e-b6d4-5a4cd73b987a	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
66992-840-10	66992084010	100 CAPSULE in 1 BOTTLE (66992-840-10)	100 capsule	2014-12-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TREZIX™ Capsules	Proficient Rx LP	2022-05-02	HUMAN PRESCRIPTION DRUG LABEL	6
TREZIX™ Capsules	Bryant Ranch Prepack	2021-12-22	HUMAN PRESCRIPTION DRUG LABEL	6
TREZIX™ Capsules	Wraser Llc	2021-02-03	HUMAN PRESCRIPTION DRUG LABEL	12